ABOUT US
MC2 Therapeutics is a commercial stage biotech company focused on developing novel treatment paradigms within immune-mediated and inflammatory conditions initially focusing on manifestations in the skin. Read more about MC2 Therapeutics.
Platform
When topical dosage form is considered most optimal our PAD Technology™ formulation and drug delivery system offer several unique advantages in the development of potent innovative new topical therapies for immune-mediated and inflammatory conditions, including stability, tolerability, delivery of drugs to target tissue and convenience of use in daily routine. Read more about our platform.
Pipeline
MC2 therapeutics is converting research in skin biology into novel treatment paradigms for immune-mediated and inflammatory conditions initially focusing on manifestations in the skin. Our innovative approach is anchored in deep understanding of skin biology – knowledge that can also be leveraged to inform approaches in other types of immune-mediated and inflammatory diseases outside of this area. Read more about our pipeline.
